Correlation Between Maccura Biotechnology and Zhongtong Guomai

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Maccura Biotechnology and Zhongtong Guomai at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maccura Biotechnology and Zhongtong Guomai into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maccura Biotechnology Co and Zhongtong Guomai Communication, you can compare the effects of market volatilities on Maccura Biotechnology and Zhongtong Guomai and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maccura Biotechnology with a short position of Zhongtong Guomai. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maccura Biotechnology and Zhongtong Guomai.

Diversification Opportunities for Maccura Biotechnology and Zhongtong Guomai

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Maccura and Zhongtong is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Maccura Biotechnology Co and Zhongtong Guomai Communication in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zhongtong Guomai Com and Maccura Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maccura Biotechnology Co are associated (or correlated) with Zhongtong Guomai. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zhongtong Guomai Com has no effect on the direction of Maccura Biotechnology i.e., Maccura Biotechnology and Zhongtong Guomai go up and down completely randomly.

Pair Corralation between Maccura Biotechnology and Zhongtong Guomai

Assuming the 90 days trading horizon Maccura Biotechnology Co is expected to under-perform the Zhongtong Guomai. But the stock apears to be less risky and, when comparing its historical volatility, Maccura Biotechnology Co is 4.93 times less risky than Zhongtong Guomai. The stock trades about -0.34 of its potential returns per unit of risk. The Zhongtong Guomai Communication is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  1,149  in Zhongtong Guomai Communication on October 6, 2024 and sell it today you would lose (148.00) from holding Zhongtong Guomai Communication or give up 12.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Maccura Biotechnology Co  vs.  Zhongtong Guomai Communication

 Performance 
       Timeline  
Maccura Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maccura Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Zhongtong Guomai Com 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Zhongtong Guomai Communication are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhongtong Guomai sustained solid returns over the last few months and may actually be approaching a breakup point.

Maccura Biotechnology and Zhongtong Guomai Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Maccura Biotechnology and Zhongtong Guomai

The main advantage of trading using opposite Maccura Biotechnology and Zhongtong Guomai positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maccura Biotechnology position performs unexpectedly, Zhongtong Guomai can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zhongtong Guomai will offset losses from the drop in Zhongtong Guomai's long position.
The idea behind Maccura Biotechnology Co and Zhongtong Guomai Communication pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios